Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients

Inclusion criteria

• As per ATP III guidelines: Baseline LDL ranging 160-189 mg/dL, TC >200 mg/dL and with no or one of the below risk factors

• Current cigarette smoking
• Family history of premature Coronary Heart Disease(CHD); in male first degree relative <55 years; in female first degree relative <65 years)
• Hypertension (BP >140/90 mmHg or on antihypertensive medication)
• Low HDL-C (<40 mg/dL)
• Age (men > 40 years)
• Impaired glucose tolerance (2-hour post 75 g OGTT glucose levels in the range of ≥140 to ≤ 200 mg/dL)
• Impaired fasting sugar (Fasting blood sugar levels in the range of ≥ 100 to ≤125 mg/dL)
• Being mentally competent and able to understand all study requirements and sign the informed consent form.

Exclusion criteria

• Patients with severe liver, renal, cardiac or brain diseases.
• Pregnant or lactating women or women of child bearing potential whom are not practicing a reliable form of birth control (either with IUD or with stable usage of oral contraceptives).
• Unable to complete follow up.
• Subjects on any medication that would affect evaluation like Statins.